Huntingtin Interactome Reveals Huntingtin Role in Regulation of Double Strand Break DNA Damage Response (DSB/DDR), Chromatin Remodeling and RNA Processing Pathways

Overview

Journal bioRxiv

Date 2025 Jan 7

PMID 39763784

Authors

Tamara Ratovitski

Chloe D Holland

Robert N OMeally

Alexey V Shevelkin

Tianze Shi

Robert N Cole

Mali Jiang

Christopher A Ross

Affiliations

Soon will be listed here.

Abstract

Huntington's Disease (HD), a progressive neurodegenerative disorder with no disease-modifying therapies, is caused by a CAG repeat expansion in the HD gene encoding polyglutamine-expanded huntingtin (HTT) protein. Mechanisms of HD cellular pathogenesis and cellular functions of the normal and mutant HTT proteins are still not completely understood. HTT protein has numerous interaction partners, and it likely provides a scaffold for assembly of multiprotein complexes many of which may be altered in HD. Previous studies have implicated DNA damage response in HD pathogenesis. Gene transcription and RNA processing has also emerged as molecular mechanisms associated with HD. Here we used multiple approaches to identify HTT interactors in the context of DNA damage stress. Our results indicate that HTT interacts with many proteins involved in the regulation of interconnected DNA repair/remodeling and RNA processing pathways. We present evidence for a role for HTT in double strand break repair mechanism. We demonstrate HTT functional interaction with a major DNA damage response kinase DNA-PKcs and association of both proteins with nuclear speckles. We show that S1181 phosphorylation of HTT is regulated by DSB, and can be carried out (at least ) by DNA-PK. Furthermore, we show HTT interactions with RNA binding proteins associated with nuclear speckles, including two proteins encoded by genes at HD modifier loci, TCERG1 and MED15, and with chromatin remodeling complex BAF. These interactions of HTT may position it as an important scaffolding intermediary providing integrated regulation of gene expression and RNA processing in the context of DNA repair mechanisms.

References

Ratovitski T, Jiang M, OMeally R, Rauniyar P, Chighladze E, Farago A . Interaction of huntingtin with PRMTs and its subsequent arginine methylation affects HTT solubility, phase transition behavior and neuronal toxicity. Hum Mol Genet. 2021; 31(10):1651-1672. PMC: 9122652. DOI: 10.1093/hmg/ddab351. View

Mikolaskova B, Jurcik M, Cipakova I, Kretova M, Chovanec M, Cipak L . Maintenance of genome stability: the unifying role of interconnections between the DNA damage response and RNA-processing pathways. Curr Genet. 2018; 64(5):971-983. DOI: 10.1007/s00294-018-0819-7. View

Hensman Moss D, Pardinas A, Langbehn D, Lo K, Leavitt B, Roos R . Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study. Lancet Neurol. 2017; 16(9):701-711. DOI: 10.1016/S1474-4422(17)30161-8. View

Lin L, Park J, Ramachandran S, Zhang Y, Tseng Y, Shen S . Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease. Hum Mol Genet. 2016; 25(16):3454-3466. PMC: 5179942. DOI: 10.1093/hmg/ddw187. View

Galganski L, Urbanek M, Krzyzosiak W . Nuclear speckles: molecular organization, biological function and role in disease. Nucleic Acids Res. 2017; 45(18):10350-10368. PMC: 5737799. DOI: 10.1093/nar/gkx759. View

Pressl C, Matlik K, Kus L, Darnell P, Luo J, Paul M . Selective vulnerability of layer 5a corticostriatal neurons in Huntington's disease. Neuron. 2024; 112(6):924-941.e10. DOI: 10.1016/j.neuron.2023.12.009. View

. Induced pluripotent stem cells from patients with Huntington's disease show CAG-repeat-expansion-associated phenotypes. Cell Stem Cell. 2012; 11(2):264-78. PMC: 3804072. DOI: 10.1016/j.stem.2012.04.027. View

. Identification of Genetic Factors that Modify Clinical Onset of Huntington's Disease. Cell. 2015; 162(3):516-26. PMC: 4524551. DOI: 10.1016/j.cell.2015.07.003. View

Tabrizi S, Flower M, Ross C, Wild E . Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities. Nat Rev Neurol. 2020; 16(10):529-546. DOI: 10.1038/s41582-020-0389-4. View

10.

Liu H, McCollum A, Krishnaprakash A, Ouyang Y, Shi T, Ratovitski T . Roscovitine, a CDK Inhibitor, Reduced Neuronal Toxicity of mHTT by Targeting HTT Phosphorylation at S1181 and S1201 In Vitro. Int J Mol Sci. 2024; 25(22). PMC: 11594617. DOI: 10.3390/ijms252212315. View

11.

Li S, Li X . Huntingtin-protein interactions and the pathogenesis of Huntington's disease. Trends Genet. 2004; 20(3):146-54. DOI: 10.1016/j.tig.2004.01.008. View

12.

Greco T, Secker C, Silva Ramos E, Federspiel J, Liu J, Perez A . Dynamics of huntingtin protein interactions in the striatum identifies candidate modifiers of Huntington disease. Cell Syst. 2022; 13(4):304-320.e5. PMC: 9317655. DOI: 10.1016/j.cels.2022.01.005. View

13.

McAllister T, England K, Hopkinson R, Brennan P, Kawamura A, Schofield C . Recent Progress in Histone Demethylase Inhibitors. J Med Chem. 2015; 59(4):1308-29. DOI: 10.1021/acs.jmedchem.5b01758. View

14.

Guccione E, Richard S . The regulation, functions and clinical relevance of arginine methylation. Nat Rev Mol Cell Biol. 2019; 20(10):642-657. DOI: 10.1038/s41580-019-0155-x. View

15.

Enokido Y, Tamura T, Ito H, Arumughan A, Komuro A, Shiwaku H . Mutant huntingtin impairs Ku70-mediated DNA repair. J Cell Biol. 2010; 189(3):425-43. PMC: 2867301. DOI: 10.1083/jcb.200905138. View

16.

Ratovitski T, Chighladze E, Arbez N, Boronina T, Herbrich S, Cole R . Huntingtin protein interactions altered by polyglutamine expansion as determined by quantitative proteomic analysis. Cell Cycle. 2012; 11(10):2006-21. PMC: 3359124. DOI: 10.4161/cc.20423. View

17.

Mouro Pinto R, Dragileva E, Kirby A, Lloret A, Lopez E, St Claire J . Mismatch repair genes Mlh1 and Mlh3 modify CAG instability in Huntington's disease mice: genome-wide and candidate approaches. PLoS Genet. 2013; 9(10):e1003930. PMC: 3814320. DOI: 10.1371/journal.pgen.1003930. View

18.

Kurosawa A . Autophosphorylation and Self-Activation of DNA-Dependent Protein Kinase. Genes (Basel). 2021; 12(7). PMC: 8305690. DOI: 10.3390/genes12071091. View

19.

Deng Q, Holler C, Taylor G, Hudson K, Watkins W, Gearing M . FUS is phosphorylated by DNA-PK and accumulates in the cytoplasm after DNA damage. J Neurosci. 2014; 34(23):7802-13. PMC: 4044245. DOI: 10.1523/JNEUROSCI.0172-14.2014. View

20.

Kegel K, Meloni A, Yi Y, Kim Y, Doyle E, Cuiffo B . Huntingtin is present in the nucleus, interacts with the transcriptional corepressor C-terminal binding protein, and represses transcription. J Biol Chem. 2001; 277(9):7466-76. DOI: 10.1074/jbc.M103946200. View